BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20206707)

  • 1. Imaging genetics in ADHD.
    Durston S
    Neuroimage; 2010 Nov; 53(3):832-8. PubMed ID: 20206707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuroimaging?
    Plomp E; Van Engeland H; Durston S
    Neuroscience; 2009 Nov; 164(1):230-40. PubMed ID: 19619618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging genetics in ADHD: a focus on cognitive control.
    Durston S; de Zeeuw P; Staal WG
    Neurosci Biobehav Rev; 2009 May; 33(5):674-89. PubMed ID: 18789356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: Genetics of attention deficit/hyperactivity disorder.
    Wallis D; Russell HF; Muenke M
    J Pediatr Psychol; 2008; 33(10):1085-99. PubMed ID: 18522996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    HenrĂ­quez B H; HenrĂ­quez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls.
    Durston S; Fossella JA; Casey BJ; Hulshoff Pol HE; Galvan A; Schnack HG; Steenhuis MP; Minderaa RB; Buitelaar JK; Kahn RS; van Engeland H
    Mol Psychiatry; 2005 Jul; 10(7):678-85. PubMed ID: 15724142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal but not performance IQ is highly correlated to externalizing behavior in boys with ADHD carrying both DRD4 and DAT1 risk genotypes.
    Kebir O; Grizenko N; Sengupta S; Joober R
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):939-44. PubMed ID: 19409950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between multi-informant assessments of ADHD symptoms, DAT1, and DRD4.
    Gizer IR; Waldman ID; Abramowitz A; Barr CL; Feng Y; Wigg KG; Misener VL; Rowe DC
    J Abnorm Psychol; 2008 Nov; 117(4):869-80. PubMed ID: 19025233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T
    Expert Rev Neurother; 2009 Oct; 9(10):1547-65. PubMed ID: 19831843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes.
    Todd RD; Huang H; Smalley SL; Nelson SF; Willcutt EG; Pennington BF; Smith SD; Faraone SV; Neuman RJ
    J Child Psychol Psychiatry; 2005 Oct; 46(10):1067-73. PubMed ID: 16178930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype.
    Neuman RJ; Lobos E; Reich W; Henderson CA; Sun LW; Todd RD
    Biol Psychiatry; 2007 Jun; 61(12):1320-8. PubMed ID: 17157268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD.
    Kim YS; Leventhal BL; Kim SJ; Kim BN; Cheon KA; Yoo HJ; Kim SJ; Badner J; Cook EH
    Neurosci Lett; 2005 Dec; 390(3):176-81. PubMed ID: 16165273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary factors in attention deficit hyperactivity disorder].
    Fliers EA; Franke B; Buitelaar JK
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1726-9. PubMed ID: 16114287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From regulatory problems in infancy to attention-deficit/hyperactivity disorder in childhood: a moderating role for the dopamine D4 receptor gene?
    Becker K; Blomeyer D; El-Faddagh M; Esser G; Schmidt MH; Banaschewski T; Laucht M
    J Pediatr; 2010 May; 156(5):798-803, 803.e1-803.e2. PubMed ID: 20172533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.